Displaying 1 - 1 of 1
Author:Abraham, Lucy Urani, Alexandre Lambru, Giorgio Lipton, Richard Goadsby, Peter Pozo-Rosich, Patricia Schwedt, Todd Galabova, Boryana Dai, Feng Hygge Blakeman, Karin
Session Name:P10: Headache: Advances in CGRP Inhibitors and Migraine 3
Topic:Headache
Program Number:P10.001
Author Institution:Pfizer R&D UK Ltd, Tadworth, Surrey , Tadworth, United Kingdom Aptar Digital Health, Paris, France, Rueil Malmaison, France The Headache and Facial Pain Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK, London, United Kingdom Montefiore Medical Center and Albert Einstein College of Medicine, New York, USA, Bronx, NY NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College Hospital/SLaM Biomedical Research Centre, King’s College London, UK and UCLA, Los Angeles, CA, USA, Los Angeles, CA Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona Headache and Craniofacial Pain Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain, Barcelona, Spain Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA, Phoenix, AZ Pfizer R&D UK Ltd, Tadworth, Surrey, London, United Kingdom Pfizer AB., Stockholm, Sweden, Stockholm, Sweden
Displaying 1 - 1 of 1